Regions https://www.bioworld.com/rss en-us China gives nod to Innovent’s limertinib NDA for lung cancer http://www.bioworld.com/articles/716556 Tue, 21 Jan 2025 12:00:00 -0500 https://www.bioworld.com/articles/716556-china-gives-nod-to-innovents-limertinib-nda-for-lung-cancer China gives nod to Innovent’s limertinib NDA for lung cancer http://www.bioworld.com/articles/716384 Fri, 17 Jan 2025 12:00:00 -0500 https://www.bioworld.com/articles/716384-china-gives-nod-to-innovents-limertinib-nda-for-lung-cancer FDA clears Vuno’s AI-based MRI reading software for early Alzheimer’s detection http://www.bioworld.com/articles/702037 Wed, 25 Oct 2023 12:00:00 -0400 https://www.bioworld.com/articles/702037-fda-clears-vunos-ai-based-mri-reading-software-for-early-alzheimers-detection Vuno Vuno’s Med-Deepbrain. Credit: Vuno Inc. China approves two more CAR T trials; Legend’s candidate gets FDA breakthrough status http://www.bioworld.com/articles/432010 Tue, 24 Dec 2019 12:00:00 -0500 https://www.bioworld.com/articles/432010-china-approves-two-more-car-t-trials-legends-candidate-gets-fda-breakthrough-status Stem cells China approves two more CAR T trials; Legend’s candidate gets FDA breakthrough status http://www.bioworld.com/articles/431963 Fri, 20 Dec 2019 12:00:00 -0500 https://www.bioworld.com/articles/431963-china-approves-two-more-car-t-trials-legends-candidate-gets-fda-breakthrough-status Analysis by U.K. startup Medbelle highlights extent of drug pricing disparity http://www.bioworld.com/articles/431381 Tue, 26 Nov 2019 11:30:00 -0500 https://www.bioworld.com/articles/431381-analysis-by-uk-startup-medbelle-highlights-extent-of-drug-pricing-disparity World map made of pills Analysis by U.K. startup Medbelle highlights extent of drug pricing disparity http://www.bioworld.com/articles/431290 Thu, 21 Nov 2019 12:00:00 -0500 https://www.bioworld.com/articles/431290-analysis-by-uk-startup-medbelle-highlights-extent-of-drug-pricing-disparity World map made of pills Courts split on DoJ authority to dismiss False Claims Act cases http://www.bioworld.com/articles/430430 Wed, 16 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/430430-courts-split-on-doj-authority-to-dismiss-false-claims-act-cases 3Q deals and M&A: Volumes down, values up; 2019 already topping last two years http://www.bioworld.com/articles/429235 Mon, 14 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429235-3q-deals-and-m-a-volumes-down-values-up-2019-already-topping-last-two-years Solid quarter for sector's global public and private financings http://www.bioworld.com/articles/429244 Mon, 07 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429244-solid-quarter-for-sectors-global-public-and-private-financings Brexit-shaped hole in U.K.'s Q3 funding for life sciences http://www.bioworld.com/articles/429588 Thu, 03 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429588-brexit-shaped-hole-in-uks-q3-funding-for-life-sciences Great Danes push YTD funding tally to $5.6B as European biotech raises $2.4B in Q3 http://www.bioworld.com/articles/429587 Thu, 03 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429587-great-danes-push-ytd-funding-tally-to-5-6b-as-european-biotech-raises-2-4b-in-q3 South Korea's Samsung Bioepis to provide Enbrel biosimilar to Brazil market http://www.bioworld.com/articles/429331 Mon, 16 Sep 2019 00:00:00 -0400 https://www.bioworld.com/articles/429331-south-koreas-samsung-bioepis-to-provide-enbrel-biosimilar-to-brazil-market Germany HTA analysis points out lack of sufficient benefit data for newly approved drugs http://www.bioworld.com/articles/347403 Fri, 12 Jul 2019 00:00:00 -0400 https://www.bioworld.com/articles/347403-germany-hta-analysis-points-out-lack-of-sufficient-benefit-data-for-newly-approved-drugs